Corient Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $259K | Hold |
3,126
| – | – | 0.02% | 512 |
|
|
2022
Q2 | $259K | Buy |
3,126
+530
| +20% | +$43.9K | 0.02% | 529 |
|
|
2022
Q1 | $200K | Sell |
2,596
-106
| -4% | -$8.17K | 0.01% | 686 |
|
|
2021
Q4 | $239K | Sell |
2,702
-123
| -4% | -$10.9K | 0.02% | 601 |
|
|
2021
Q3 | $218K | Buy |
2,825
+212
| +8% | +$16.4K | 0.02% | 610 |
|
|
2021
Q2 | $218K | Buy |
+2,613
| New | +$218K | 0.02% | 599 |
|
|
2021
Q1 | – | Sell |
-2,292
| Closed | -$201K | – | 619 |
|
|
2020
Q4 | $201K | Buy |
+2,292
| New | +$201K | 0.02% | 481 |
|
|
2020
Q3 | – | Sell |
-9,955
| Closed | -$1.23M | – | 511 |
|
|
2020
Q2 | $1.23M | Buy |
9,955
+1,899
| +24% | +$234K | 0.15% | 131 |
|
|
2020
Q1 | $680K | Buy |
+8,056
| New | +$680K | 0.11% | 165 |
|